Literature DB >> 7031544

The effects of chronic gastrointestinal medication on the fetus and neonate.

F R Witter, T M King, D A Blake.   

Abstract

The adverse fetal and neonatal effects of chronic gastrointestinal medication have been reviewed. The major classes discussed are antiemetics, laxatives and antidiarrheal agents, antacids and cimetidine, drugs for irritable bowel syndrome, and drugs for inflammatory bowel disease. The evaluation given are tentative due to the lack of information on most of these drugs. It is hoped that research into the use of this diverse group of medications during pregnancy will be stimulated, so that the large gaps in our knowledge about them can be filled.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7031544

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

Review 1.  Nausea and vomiting of pregnancy.

Authors:  Noel M Lee; Sumona Saha
Journal:  Gastroenterol Clin North Am       Date:  2011-06       Impact factor: 3.806

2.  Prescribing in pregnancy. Identifying abnormalities.

Authors:  M J Whittle; K P Hanretty
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

Review 3.  Nausea and vomiting of pregnancy - What's new?

Authors:  Martha Bustos; Raman Venkataramanan; Steve Caritis
Journal:  Auton Neurosci       Date:  2016-05-13       Impact factor: 3.145

Review 4.  Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?

Authors:  C N Broussard; J E Richter
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

Review 5.  Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: A review.

Authors:  Mansour Altuwaijri
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

Review 6.  Interventions for heartburn in pregnancy.

Authors:  Vorapong Phupong; Tharangrut Hanprasertpong
Journal:  Cochrane Database Syst Rev       Date:  2015-09-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.